Search results
Huma.AI Announces Its Joining Microsoft Pegasus Program to Develop Next- Generation AI in Life ...
PRWeb· 7 days agoHuma.AI has joined the Microsoft Pegasus Program to enhance its generative AI platform for the life sciences industry. This collaboration with Microsoft will...
Data science, theater, agronomy are part of plans for the Academic All-State 2024 Top 10
The Des Moines Register via Yahoo News· 6 days agoMy plan for college is to double major in two distinctly different tracks – one for my head and one...
Registration open for Macon Resources Inc. Kids Programs
Herald & Review· 10 hours agoRegistration for summer programs is now open for Macon Resources Inc. Kids services.
Community science volunteers can set scientific world abuzz with new bumble bee sightings
Phys.org· 4 days agoIt is buzz-worthy confirmation that community science programs can play an important role in...
Beijing, Seoul illuminate science, tech innovation
China Daily· 1 hour agoIn a rapidly evolving global technological landscape, China continues to make significant strides in science and technology despite facing economic challenges. With substantial ...
NASA Open Science Funding Opportunities - NASA Science
NASA· 2 days agoNASA offers a number of opportunities in the Research Opportunities for Space and Earth Science...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
KOLR - KSFX Ozarks· 2 days agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European ...
From Black Gold to Green Energy: Mining Rare Earths Alongside Coal
SciTechDaily· 3 hours agoNew research documents elevated levels of these metals, needed for energy transition, above and...
SUNY Sullivan deactivates several academic programs - Mid Hudson News
Mid Hudson News· 17 hours agoLOCH SHELDRAKE- In an effort to optimize resources and improve the quality of education, the Board...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
KSAN - KLST San Angelo· 2 days agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European ...